The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global SARS-Cov-2 Vaccine (Vero Cell) Market Research Report 2025
Synopsis
SARS-Cov-2 Vaccine (Vero Cell) is an immune product made to prevent and control the occurrence and prevalence of infectious diseases caused by the new coronavirus
The global SARS-Cov-2 Vaccine (Vero Cell) market was valued at US$ 11900 million in 2023 and is anticipated to reach US$ 27560 million by 2030, witnessing a CAGR of 11.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for SARS-Cov-2 Vaccine (Vero Cell), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SARS-Cov-2 Vaccine (Vero Cell).
Report Scope
The SARS-Cov-2 Vaccine (Vero Cell) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global SARS-Cov-2 Vaccine (Vero Cell) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the SARS-Cov-2 Vaccine (Vero Cell) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sinopharm
Sinovac Biotech
BIBP
IMBCAMS,China
WIBP
Pfizer
Segment by Type
Whole Virus Inactivated Vaccine
Split Vaccine
Subunit Vaccine
Others
Segment by Application
Special Population
General Population
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of SARS-Cov-2 Vaccine (Vero Cell) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of SARS-Cov-2 Vaccine (Vero Cell) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
SARS-Cov-2 Vaccine (Vero Cell) is an immune product made to prevent and control the occurrence and prevalence of infectious diseases caused by the new coronavirus
The global SARS-Cov-2 Vaccine (Vero Cell) market was valued at US$ 11900 million in 2023 and is anticipated to reach US$ 27560 million by 2030, witnessing a CAGR of 11.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for SARS-Cov-2 Vaccine (Vero Cell), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SARS-Cov-2 Vaccine (Vero Cell).
Report Scope
The SARS-Cov-2 Vaccine (Vero Cell) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global SARS-Cov-2 Vaccine (Vero Cell) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the SARS-Cov-2 Vaccine (Vero Cell) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sinopharm
Sinovac Biotech
BIBP
IMBCAMS,China
WIBP
Pfizer
Segment by Type
Whole Virus Inactivated Vaccine
Split Vaccine
Subunit Vaccine
Others
Segment by Application
Special Population
General Population
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of SARS-Cov-2 Vaccine (Vero Cell) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of SARS-Cov-2 Vaccine (Vero Cell) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 SARS-Cov-2 Vaccine (Vero Cell) Market Overview
1.1 Product Overview and Scope of SARS-Cov-2 Vaccine (Vero Cell)
1.2 SARS-Cov-2 Vaccine (Vero Cell) Segment by Type
1.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Value Comparison by Type (2024-2030)
1.2.2 Whole Virus Inactivated Vaccine
1.2.3 Split Vaccine
1.2.4 Subunit Vaccine
1.2.5 Others
1.3 SARS-Cov-2 Vaccine (Vero Cell) Segment by Application
1.3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Value by Application: (2024-2030)
1.3.2 Special Population
1.3.3 General Population
1.4 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Estimates and Forecasts
1.4.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue 2019-2030
1.4.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales 2019-2030
1.4.3 Global SARS-Cov-2 Vaccine (Vero Cell) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 SARS-Cov-2 Vaccine (Vero Cell) Market Competition by Manufacturers
2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Manufacturers (2019-2024)
2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Average Price by Manufacturers (2019-2024)
2.4 Global SARS-Cov-2 Vaccine (Vero Cell) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of SARS-Cov-2 Vaccine (Vero Cell), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of SARS-Cov-2 Vaccine (Vero Cell), Product Type & Application
2.7 SARS-Cov-2 Vaccine (Vero Cell) Market Competitive Situation and Trends
2.7.1 SARS-Cov-2 Vaccine (Vero Cell) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest SARS-Cov-2 Vaccine (Vero Cell) Players Market Share by Revenue
2.7.3 Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 SARS-Cov-2 Vaccine (Vero Cell) Retrospective Market Scenario by Region
3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region: 2019-2030
3.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region: 2019-2024
3.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region: 2025-2030
3.3 Global SARS-Cov-2 Vaccine (Vero Cell) Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region: 2019-2030
3.3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region: 2019-2024
3.3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region: 2025-2030
3.4 North America SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Country
3.4.1 North America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2019-2030)
3.4.3 North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Country
3.5.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2019-2030)
3.5.3 Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Country
3.6.1 Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2019-2030)
3.6.3 Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Country
3.7.1 Latin America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2019-2030)
3.7.3 Latin America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Country
3.8.1 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2019-2030)
3.8.3 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2019-2030)
4.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2019-2024)
4.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2025-2030)
4.1.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2019-2030)
4.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2019-2030)
4.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2019-2024)
4.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2025-2030)
4.2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2019-2030)
4.3 Global SARS-Cov-2 Vaccine (Vero Cell) Price by Type (2019-2030)
5 Segment by Application
5.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2019-2030)
5.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2019-2024)
5.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2025-2030)
5.1.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2019-2030)
5.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2019-2030)
5.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2019-2024)
5.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2025-2030)
5.2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2019-2030)
5.3 Global SARS-Cov-2 Vaccine (Vero Cell) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sinopharm
6.1.1 Sinopharm Corporation Information
6.1.2 Sinopharm Description and Business Overview
6.1.3 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
6.1.5 Sinopharm Recent Developments/Updates
6.2 Sinovac Biotech
6.2.1 Sinovac Biotech Corporation Information
6.2.2 Sinovac Biotech Description and Business Overview
6.2.3 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
6.2.5 Sinovac Biotech Recent Developments/Updates
6.3 BIBP
6.3.1 BIBP Corporation Information
6.3.2 BIBP Description and Business Overview
6.3.3 BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
6.3.5 BIBP Recent Developments/Updates
6.4 IMBCAMS,China
6.4.1 IMBCAMS,China Corporation Information
6.4.2 IMBCAMS,China Description and Business Overview
6.4.3 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
6.4.5 IMBCAMS,China Recent Developments/Updates
6.5 WIBP
6.5.1 WIBP Corporation Information
6.5.2 WIBP Description and Business Overview
6.5.3 WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
6.5.5 WIBP Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 SARS-Cov-2 Vaccine (Vero Cell) Industry Chain Analysis
7.2 SARS-Cov-2 Vaccine (Vero Cell) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 SARS-Cov-2 Vaccine (Vero Cell) Production Mode & Process
7.4 SARS-Cov-2 Vaccine (Vero Cell) Sales and Marketing
7.4.1 SARS-Cov-2 Vaccine (Vero Cell) Sales Channels
7.4.2 SARS-Cov-2 Vaccine (Vero Cell) Distributors
7.5 SARS-Cov-2 Vaccine (Vero Cell) Customers
8 SARS-Cov-2 Vaccine (Vero Cell) Market Dynamics
8.1 SARS-Cov-2 Vaccine (Vero Cell) Industry Trends
8.2 SARS-Cov-2 Vaccine (Vero Cell) Market Drivers
8.3 SARS-Cov-2 Vaccine (Vero Cell) Market Challenges
8.4 SARS-Cov-2 Vaccine (Vero Cell) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global SARS-Cov-2 Vaccine (Vero Cell) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global SARS-Cov-2 Vaccine (Vero Cell) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global SARS-Cov-2 Vaccine (Vero Cell) Market Competitive Situation by Manufacturers in 2023
Table 4. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market SARS-Cov-2 Vaccine (Vero Cell) Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of SARS-Cov-2 Vaccine (Vero Cell), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of SARS-Cov-2 Vaccine (Vero Cell), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of SARS-Cov-2 Vaccine (Vero Cell), Product Type & Application
Table 12. Global Key Manufacturers of SARS-Cov-2 Vaccine (Vero Cell), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global SARS-Cov-2 Vaccine (Vero Cell) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SARS-Cov-2 Vaccine (Vero Cell) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2019-2024) & (K Units)
Table 18. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2019-2024)
Table 19. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2025-2030) & (K Units)
Table 20. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2025-2030)
Table 21. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2019-2024)
Table 23. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2025-2030)
Table 25. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2019-2024) & (K Units)
Table 27. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2025-2030) & (K Units)
Table 28. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2019-2024) & (K Units)
Table 32. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2025-2030) & (K Units)
Table 33. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) by Type (2019-2024)
Table 51. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) by Type (2025-2030)
Table 52. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2019-2024)
Table 53. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2025-2030)
Table 54. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2019-2024)
Table 57. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2025-2030)
Table 58. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Type (2019-2024)
Table 59. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Type (2025-2030)
Table 60. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) by Application (2019-2024)
Table 61. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) by Application (2025-2030)
Table 62. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2019-2024)
Table 63. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2025-2030)
Table 64. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2019-2024)
Table 67. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2025-2030)
Table 68. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Application (2019-2024)
Table 69. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Application (2025-2030)
Table 70. Sinopharm Corporation Information
Table 71. Sinopharm Description and Business Overview
Table 72. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product
Table 74. Sinopharm Recent Developments/Updates
Table 75. Sinovac Biotech Corporation Information
Table 76. Sinovac Biotech Description and Business Overview
Table 77. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product
Table 79. Sinovac Biotech Recent Developments/Updates
Table 80. BIBP Corporation Information
Table 81. BIBP Description and Business Overview
Table 82. BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. BIBP SARS-Cov-2 Vaccine (Vero Cell) Product
Table 84. BIBP Recent Developments/Updates
Table 85. IMBCAMS,China Corporation Information
Table 86. IMBCAMS,China Description and Business Overview
Table 87. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product
Table 89. IMBCAMS,China Recent Developments/Updates
Table 90. WIBP Corporation Information
Table 91. WIBP Description and Business Overview
Table 92. WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. WIBP SARS-Cov-2 Vaccine (Vero Cell) Product
Table 94. WIBP Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer SARS-Cov-2 Vaccine (Vero Cell) Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. SARS-Cov-2 Vaccine (Vero Cell) Distributors List
Table 103. SARS-Cov-2 Vaccine (Vero Cell) Customers List
Table 104. SARS-Cov-2 Vaccine (Vero Cell) Market Trends
Table 105. SARS-Cov-2 Vaccine (Vero Cell) Market Drivers
Table 106. SARS-Cov-2 Vaccine (Vero Cell) Market Challenges
Table 107. SARS-Cov-2 Vaccine (Vero Cell) Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of SARS-Cov-2 Vaccine (Vero Cell)
Figure 2. Global SARS-Cov-2 Vaccine (Vero Cell) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Type in 2023 & 2030
Figure 4. Whole Virus Inactivated Vaccine Product Picture
Figure 5. Split Vaccine Product Picture
Figure 6. Subunit Vaccine Product Picture
Figure 7. Others Product Picture
Figure 8. Global SARS-Cov-2 Vaccine (Vero Cell) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Application in 2023 & 2030
Figure 10. Special Population
Figure 11. General Population
Figure 12. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size (2019-2030) & (US$ Million)
Figure 14. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (2019-2030) & (K Units)
Figure 15. Global SARS-Cov-2 Vaccine (Vero Cell) Average Price (US$/Unit) & (2019-2030)
Figure 16. SARS-Cov-2 Vaccine (Vero Cell) Report Years Considered
Figure 17. SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Manufacturers in 2023
Figure 18. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest SARS-Cov-2 Vaccine (Vero Cell) Players: Market Share by Revenue in 2023
Figure 20. SARS-Cov-2 Vaccine (Vero Cell) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2019-2030)
Figure 23. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2019-2030)
Figure 24. United States SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2019-2030)
Figure 27. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2019-2030)
Figure 28. Germany SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2019-2030)
Figure 35. China SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2019-2030)
Figure 45. Latin America SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2019-2030)
Figure 46. Mexico SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2019-2030)
Figure 51. Turkey SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Type (2019-2030)
Figure 55. Global Revenue Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Type (2019-2030)
Figure 56. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Application (2019-2030)
Figure 58. Global Revenue Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Application (2019-2030)
Figure 59. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Application (2019-2030)
Figure 60. SARS-Cov-2 Vaccine (Vero Cell) Value Chain
Figure 61. SARS-Cov-2 Vaccine (Vero Cell) Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
